Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2) - Silberstein, Stephen D.; Stauffer, Virginia L.; Day, Katie A.; Lipsius, Sarah; Wilson, Maria-Carmen (Journal of headache and pain, 2019)
Keywords: Adolescent; Adult; Aged; Antibodies, Monoclonal - therapeutic use; Antibodies, Monoclonal, Humanized; Calcitonin; Calcitonin gene-related peptide; Clinical trials; Double-Blind Method; Episodic migraine; Female; Galcanezumab; Headache; Headaches; Humans; Hyperacusis - etiology; Internal Medicine; Male; Medicine; Medicine & Public Health; Middle Aged; Migraine; Migraine Disorders - complications; Migraine Disorders - diagnosis; Migraine Disorders - drug therapy; Migraine frequency; Monoclonal antibodies; Nausea; Nausea - etiology; Neurology; Pain Medicine; Photophobia - etiology; Placebos; Quality of Life; Research Article; Treatment Outcome; Vomiting; Vomiting - etiology; Young Adult; Episodic migraine; Migraine frequency; Galcanezumab